Ziwei and co-workers (2007) discovered that Akt activation in oropharyngeal squamous cell carcinoma (OSCC) is associated with adverse patient outcome, indicating that Akt is a promising molecular target in oropharyngeal squamous cell carcinoma. This evidence concerns the gene AKT1 and oropharynx squamous cell carcinoma.